Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01155336 · ClinicalTrials.gov registry record · Phase 1
The Effects of Lovaza® in Acute Myocardial Infarction
A Phase 1 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01155336 is a Phase 1 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 4 participants.
The verdict
NCT01155336, a Phase 1 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will explore the safety and effectiveness of adding Lovaza® to the therapeutic program utilized internationally for the treatment of individuals with acute coronary syndromes.
Interventions
- DRUG Lovaza®
- DRUG The placebo contained 1 gram of corn oil in each capsule.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01155336
The ClinicalTrials.gov registry entry for NCT01155336 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lovaza® is the first listed.
NCT01155336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01155336 about?
NCT01155336 is a clinical study titled "The Effects of Lovaza® in Acute Myocardial Infarction". This study will explore the safety and effectiveness of adding Lovaza® to the therapeutic program utilized internationally for the treatment of individuals with acute coronary syndromes.
What is the current status of trial NCT01155336?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2010-06. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01155336?
The interventions under investigation include: Lovaza® (DRUG), The placebo contained 1 gram of corn oil in each capsule. (DRUG).
Who is sponsoring clinical trial NCT01155336?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.